BRENX LTD. BRNX
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-57.14
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $387.0K | — | $621.0K | $1.5M | $395.0K | — | — |
| Cost of revenue | $3.6M | $985.0K | $1.6M | $1.9M | $4.1M | — | — |
| Gross profit | -$3.2M | — | -$934.0K | -$370.0K | -$3.7M | — | — |
| R&D | $4.0M | $3.6M | $3.2M | $4.7M | $3.7M | — | — |
| SG&A | $4.3M | $4.6M | $4.6M | $4.4M | $638.0K | — | — |
| Operating income | -$12.7M | -$10.6M | -$9.9M | -$11.7M | -$10.9M | — | — |
| Interest expense | $374.0K | $244.0K | $100.0K | $92.0K | $145.0K | — | — |
| Net income | -$13.9M | -$6.8M | -$9.6M | -$11.1M | -$11.0M | -$9.5M | — |
| EPS, basic | -57.14 | -45.27 | -174.63 | -7.58 | -9.23 | — | — |
| EPS, diluted | -57.14 | -45.27 | -174.63 | -7.58 | -9.23 | — | — |
| Shares, diluted (wtd. avg.) | 408,792 | 149,585 | 55,774 | 1.5M | 1.2M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.9M | $4.1M | $3.2M | $6.5M | $8.3M | $2.3M | — |
| Receivables | — | — | $278.0K | $657.0K | — | — | — |
| Inventory | $1.6M | $1.6M | $607.0K | $935.0K | — | — | — |
| Total current assets | $7.0M | $6.3M | $4.6M | $8.7M | — | — | — |
| Property, plant and equipment | $4.4M | $4.9M | $4.6M | $1.9M | — | — | — |
| Total assets | $12.5M | $11.9M | $10.6M | $12.5M | $14.6M | — | — |
| Accounts payable | $712.0K | $275.0K | $385.0K | $305.0K | — | — | — |
| Total current liabilities | $5.2M | $2.8M | $2.7M | $2.6M | — | — | — |
| Long-term debt | $5.2M | — | $5.3M | — | — | — | — |
| Total liabilities | $9.0M | $7.4M | $7.7M | $7.8M | — | — | — |
| Retained earnings | -$116.1M | -$102.2M | -$95.4M | -$85.8M | — | — | — |
| Total equity | $3.5M | $4.5M | $2.9M | $4.6M | $7.7M | $2.5M | -$558.0K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.4M | -$9.5M | -$6.9M | -$11.7M | -$8.5M | — | — |
| Depreciation and amortisation | $561.0K | $228.0K | $120.0K | $239.0K | $250.0K | — | — |
| Stock-based compensation | $1.2M | $1.4M | $1.8M | $1.5M | $236.0K | — | — |
| Capital expenditure | $13.0K | $37.0K | $33.0K | $39.0K | $47.0K | — | — |
| Investing cash flow | -$398.0K | -$422.0K | -$2.6M | -$1.4M | -$248.0K | — | — |
| Financing cash flow | $11.5M | $10.9M | $6.4M | $11.2M | $14.7M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-034046.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $395.0K | $1.5M | $621.0K | — | $387.0K |
| Gross profit | — | — | -$3.7M | -$370.0K | -$934.0K | — | -$3.2M |
| Net income | — | -$9.5M | -$11.0M | -$11.1M | -$9.6M | -$6.8M | -$13.9M |
Others in SIC 3433
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BW | Babcock & Wilcox Enterprises, Inc. | $618.2M | — | 1.1% |